Security key
15117F500
Cellectar Biosciences, Inc. - Common Stock (CLRB)
CUSIP: 15117F500
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 12,486,174
- Total 13F value
- $14,874,276
- Share change
- -2,780,731
- SEC-reported price per share
- $1.19
- Number of holders
- 42
- Value change
- -$4,685,208
- Number of buys
- 25
- Number of sells
- 14
- Shares outstanding
- 8,719,970
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
42
Top holders
10
CLRB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2021
Previous quarter: Q1 2021
Cellectar Biosciences, Inc. SEC filings
Cellectar Biosciences, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 15117F500
Recent filing periods:
Ownership snapshot
Top reported holders of CLRB - Cellectar Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Consonance Capital Manage...
Disclosed value leader
Consonance Capital Manage...
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F
Lead comparable stake: 47%
Showing 1-6 of 15 holder rows.
Quick read
Consonance Capital Management LP leads the comparable SEC ownership view at 47%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Consonance Capital Management LP's linked filing trail.
Comparable ownership
Top 5
Consonance Capital Management LP
47%
Sio Capital Management, LLC
25%
VANGUARD GROUP INC
19%
Boxer Capital, LLC
11%
Maven Securities LTD
10%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Consonance Capital Management LP |
13F
Company
|
47%
|
$6,559,000
4,074,074 shares
|
— | 31 Mar 2021 |
| Sio Capital Management, LLC |
13F
Company
|
25%
|
$3,523,000
2,188,058 shares
|
— | 31 Mar 2021 |
| VANGUARD GROUP INC |
13F
Company
|
19%
|
$2,645,000
1,643,404 shares
|
— | 31 Mar 2021 |
| Boxer Capital, LLC |
13F
Company
|
11%
|
$1,481,000
920,000 shares
|
— | 31 Mar 2021 |
| Maven Securities LTD |
13F
Company
|
10%
|
$1,447,000
900,000 shares
|
— | 31 Mar 2021 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
10%
|
$1,437,000
892,557 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
42
Shares
12,486,174
Rows available
42
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
42
Q2 2021 holders
42
Holder diff
0
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend